Cover Image
Market Research Report

Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022

Published by MarketsandMarkets Product code 366851
Published Content info 336 Pages
Immediate Delivery Available
Price
Back to Top
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022
Published: September 22, 2017 Content info: 336 Pages
Description

"Life science instrumentation market projected to grow at a CAGR of 6.7%"

The global life science instrumentation market is expected to reach USD 75.24 billion by 2022 from USD 54.49 million in 2017, at a CAGR of 6.7%. Increasing spending on pharmaceutical R&D, growing food safety concerns, availability of public and private funding for life science research, and continuous technological advancements in analytical instruments are some of the key factors driving the growth of this market. However, the high cost of instruments and the dearth of skilled professionals are expected to restrain market growth to a certain extent.

"The spectroscopy segment is expected to dominate the global life science instrumentation market by technology during the forecast period"

By technology, the life science instrumentation market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The spectroscopy segment is expected to account for the largest share of the global life science instrumentation market in 2017 owing to the increasing use of spectroscopy instruments in the drug safety process. In addition, the increasing use of spectroscopy in combination with other technologies, such as chromatography, in various applications is also driving the growth of this market.

"The research applications segment is expected to dominate the global life science instrumentation market during the forecast period"

On the basis of application, the life science instrumentation market is segmented into research applications, clinical and diagnostic applications, and other applications. The research applications segment is expected to account for the largest share of the global life science instrumentation market in 2017 owing to launch of technologically advanced life science instruments for the drug discovery process, increasing research activities, growth in the number of preclinical and clinical trials, and increasing adoption of high-throughput life science instruments in drug development and drug discovery.

"Asia Pacific is projected to witness the highest growth during the forecast period "

While North America is expected to account for the largest share of the market in 2017, APAC is expected to register the highest growth rate during the forecast period (2017-2022). This is owing to the rising focus of key market players in emerging Asian countries; increasing crop research studies in Asia to feed its growing population; the growing pharmaceutical industry in India and China; the large biomedical industry in Singapore; and rising number of conferences, exhibitions, and meetings on analytical instruments across the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 -25%, Tier 2 -30% and Tier 3 -45%
  • By Designation - C level - 12%, Director level - 24%, Others - 64%
  • By Region - North America - 34%, Europe - 26%, APAC - 35%, RoW - 5%

The major players in the market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bruker Corporation (US), PerkinElmer, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Horiba Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Hitachi High-Technologies Corporation (Japan), Eppendorf AG (Germany), QIAGEN N.V. (Netherlands), GE Healthcare (US), and Merck KGaA (Germany), among others.

Research Coverage:

This report studies the life science instrumentation market based on technology, applications, and end users. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

This research focuses on various levels of analysis-industry trends, vendor dive analysis of 25 market players, and company profiles of key 15 market players. This report also includes basic views on the competitive landscape, emerging and high-growth segments of the life science instrumentation market, high-growth regions and countries, and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on business strategies adopted by the major players in the life science instrumentation market. The report analyzes the life science instrumentation market by technology, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the life science instrumentation market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various life science instrumentation products across geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science instrumentation market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products distribution networks, and manufacturing capabilities of leading players in the life science instrumentation market.
Table of Contents
Product Code: AST 4499

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Breakdown of primaries
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2017
  • 4.3. LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION (2017 VS 2022)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE LIFE SCIENCE INSTRUMENTATION MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing spending on pharmaceutical R&D
      • 5.2.1.2. Growing food safety concerns
      • 5.2.1.3. Technological advancements in analytical instruments
      • 5.2.1.4. Increasing public-private investments in life science research
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of instruments
      • 5.2.2.2. Dearth of skilled professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth opportunities in emerging countries
        • 5.2.3.1.1. Growing demand for analytical instruments and focus of key market players on emerging countries
        • 5.2.3.1.2. Growth of the pharmaceutical and biotechnology industry
      • 5.2.3.2. Rising demand for analytical instruments in proteomics
      • 5.2.3.3. Growing application horizons of analytical instruments
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Inadequate infrastructure for research in emerging countries
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. RISING FOCUS ON INSTRUMENT MINIATURIZATION
    • 5.3.2. INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES
    • 5.3.3. TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS
    • 5.3.4. MARKET CONSOLIDATION

6. LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. SPECTROSCOPY
    • 6.2.1. DRIVERS
      • 6.2.1.1. Atomic spectroscopy to aid in drug safety processes and medical research
    • 6.2.2. RESTRAINTS
      • 6.2.2.1. High costs
    • 6.2.3. SPECTROSCOPY MARKET, BY TYPE
      • 6.2.3.1. Mass spectrometers
      • 6.2.3.2. Molecular spectrometers
      • 6.2.3.3. Atomic spectrometers
    • 6.2.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.3. CHROMATOGRAPHY
    • 6.3.1. DRIVERS
      • 6.3.1.1. New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT
      • 6.3.1.2. Industry support for research laboratories and academic institutes
      • 6.3.1.3. Rise in government investments for chromatography technologies
      • 6.3.1.4. Growing importance of chromatography tests in drug approvals
    • 6.3.2. RESTRAINTS
      • 6.3.2.1. High cost of equipment
    • 6.3.3. CHROMATOGRAPHY MARKET, BY PRODUCT TYPE
      • 6.3.3.1. Liquid chromatography (LC) systems
      • 6.3.3.2. Gas chromatography (GC) systems
      • 6.3.3.3. Supercritical fluid chromatography (SFC) systems
      • 6.3.3.4. Thin-layer shromatography (TLC) systems
    • 6.3.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.4. PCR
    • 6.4.1. DRIVERS
      • 6.4.1.1. Rising incidence of infectious diseases and genetic disorders
      • 6.4.1.2. Technological advancements
    • 6.4.2. RESTRAINTS
      • 6.4.2.1. High device costs associated with dPCR
      • 6.4.2.2. Technical limitations of qPCR and dPCR techniques
    • 6.4.3. PCR MARKET, BY TYPE
      • 6.4.3.1. qPCR
        • 6.4.3.1.1. Market Share Analysis, By Key Player
      • 6.4.3.2. dPCR
        • 6.4.3.2.1. Market Share Analysis, By Key Player
  • 6.5. IMMUNOASSAYS
    • 6.5.1. DRIVERS
      • 6.5.1.1. Growing prevalence of infectious and chronic diseases
      • 6.5.1.2. Sensitivity, cost advantages, and rapid analysis offered by immunoassays
      • 6.5.1.3. Increasing health awareness
    • 6.5.2. RESTRAINTS
      • 6.5.2.1. Low detection restricts adoption of immunoassay tests
    • 6.5.3. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.6. LYOPHILIZATION
    • 6.6.1. DRIVERS
      • 6.6.1.1. Increasing demand for food preservation
      • 6.6.1.2. Rising demand for lyophilized products
    • 6.6.2. RESTRAINTS
      • 6.6.2.1. High setup and maintenance cost of freeze drying equipment
      • 6.6.2.2. Increasing utilization of alternative drying technologies in pharmaceutical and biotechnology industries
    • 6.6.3. LYOPHILIZATION EQUIPMENT MARKET, BY TYPE
      • 6.6.3.1. Tray-style freeze dryers
      • 6.6.3.2. Manifold freeze dryers
      • 6.6.3.3. Shell (Rotary) freeze dryers
    • 6.6.4. MARKET ANALYSIS, BY KEY PLAYER
  • 6.7. LIQUID HANDLING
    • 6.7.1. DRIVERS
      • 6.7.1.1. Increasing focus on data precision and accuracy
      • 6.7.1.2. Technological advancements to boost the adoption of liquid handling systems
    • 6.7.2. RESTRAINTS
      • 6.7.2.1. Economic downturn and pricing limitations
    • 6.7.3. LIQUID HANDLING MARKET, BY PRODUCT TYPE
      • 6.7.3.1. Electronic Liquid Handling Systems
      • 6.7.3.2. Automated liquid handling systems
      • 6.7.3.3. Manual liquid handling systems
    • 6.7.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.8. CLINICAL CHEMISTRY ANALYZERS
    • 6.8.1. DRIVERS
      • 6.8.1.1. Increasing prevalence of lifestyle diseases
      • 6.8.1.2. Increase in laboratory automation
    • 6.8.2. RESTRAINTS
      • 6.8.2.1. Requirement of high capital investments
      • 6.8.2.2. High degree of consolidation to act as an entry barrier for new players
    • 6.8.3. MARKET ANALYSIS, BY KEY PLAYER
  • 6.9. MICROSCOPY
    • 6.9.1. DRIVERS
      • 6.9.1.1. Rising focus on nanotechnology
      • 6.9.1.2. Public-private investments for the development of advanced microscopes
      • 6.9.1.3. Technological advancements
    • 6.9.2. RESTRAINTS
      • 6.9.2.1. High cost of advanced microscopes
    • 6.9.3. MICROSCOPY MARKET, BY PRODUCT TYPE
      • 6.9.3.1. Optical microscopes
      • 6.9.3.2. Electron microscopes
      • 6.9.3.3. Scanning probe microscopes
      • 6.9.3.4. Other microscopes
    • 6.9.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.10. FLOW CYTOMETRY
    • 6.10.1. DRIVERS
      • 6.10.1.1. Technological advancements in flow cytometry instruments
      • 6.10.1.2. Growing adoption of flow cytometry techniques in research activities
    • 6.10.2. RESTRAINTS
      • 6.10.2.1. High cost of instruments
      • 6.10.2.2. Lack of awareness and technological knowledge regarding the use of flow cytometers
    • 6.10.3. FLOW CYTOMETRY MARKET, BY PRODUCT TYPE
      • 6.10.3.1. Cell analyzers
      • 6.10.3.2. Cell sorters
    • 6.10.4. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.11. NEXT-GENERATION SEQUENCING (NGS)
    • 6.11.1. DRIVERS
      • 6.11.1.1. Focus on technological advancements in sequencing platforms
      • 6.11.1.2. Increasing applications of NGS
      • 6.11.1.3. Growing number of partnerships and collaborations
    • 6.11.2. RESTRAINTS
      • 6.11.2.1. Dearth of skilled professionals
    • 6.11.3. MARKET SHARE ANALYSIS, BY KEY PLAYER
  • 6.12. CENTRIFUGES
    • 6.12.1. DRIVERS
      • 6.12.1.1. Technological advancements
      • 6.12.1.2. Increasing biopharmaceutical research activities
    • 6.12.2. RESTRAINTS
      • 6.12.2.1. Long equipment lifespan leads to low sales
    • 6.12.3. CENTRIFUGES MARKET, BY TYPE
      • 6.12.3.1. Microcentrifuges
      • 6.12.3.2. Multipurpose centrifuges
      • 6.12.3.3. Floor-standing centrifuges
      • 6.12.3.4. Ultracentrifuges
    • 6.12.4. MARKET ANALYSIS, BY KEY PLAYER
  • 6.13. ELECTROPHORESIS
    • 6.13.1. DRIVERS
      • 6.13.1.1. Growth in funding for research on genomic, proteomic, and electrophoresis technique
      • 6.13.1.2. Growing number of industry-academia collaborations
      • 6.13.1.3. Growing use of capillary electrophoresis (CE) with mass spectroscopy (MS)
    • 6.13.2. RESTRAINTS
      • 6.13.2.1. Presence of alternative technologies offering better efficiency & results
      • 6.13.2.2. Time-consuming operations and limited sample analysis
    • 6.13.3. ELECTROPHORESIS MARKET, BY PRODUCT TYPE
      • 6.13.3.1. Gel electrophoresis systems
        • 6.13.3.1.1. Market share analysis, by key player
      • 6.13.3.2. Capillary electrophoresis systems
        • 6.13.3.2.1. Market share analysis, by key player
  • 6.14. CELL COUNTING
    • 6.14.1. DRIVERS
      • 6.14.1.1. Corporate & government funding and investments for cell-based research
      • 6.14.1.2. Development of enhanced informatics solutions and improved image analysis instruments
    • 6.14.2. RESTRAINTS
      • 6.14.2.1. High price of advanced cell counting systems
      • 6.14.2.2. Reluctance among researchers to use advanced cell counting techniques
    • 6.14.3. CELL COUNTING MARKET, BY PRODUCT TYPE
      • 6.14.3.1. Automated cell counters
      • 6.14.3.2. Hemocytometers and manual cell counters
    • 6.14.4. MARKET ANALYSIS, BY KEY PLAYER
  • 6.15. OTHER TECHNOLOGIES
    • 6.15.1. LABORATORY FREEZERS
      • 6.15.1.1. Freezers
      • 6.15.1.2. Refrigerators
      • 6.15.1.3. Cryopreservation systems
    • 6.15.2. HEAT STERILIZATION
      • 6.15.2.1. Moist heat sterilization (Autoclaves)
      • 6.15.2.2. Dry heat
    • 6.15.3. MICROPLATE SYSTEMS
      • 6.15.3.1. Microplate readers
      • 6.15.3.2. Microplate dispensers
      • 6.15.3.3. Microplate washers
    • 6.15.4. LABORATORY BALANCES
    • 6.15.5. COLORIMETERS
    • 6.15.6. INCUBATORS
    • 6.15.7. FUME HOODS
    • 6.15.8. STANDALONE ROBOTS
      • 6.15.8.1. Robotic arms
      • 6.15.8.2. Track robot systems
    • 6.15.9. PH METERS
    • 6.15.10. CONDUCTIVITY AND RESISTIVITY METERS
    • 6.15.11. DISSOLVED CO2 AND O2 METERS
    • 6.15.12. TITRATORS
    • 6.15.13. GAS ANALYZERS
    • 6.15.14. TOC ANALYZERS
    • 6.15.15. THERMAL ANALYZERS

7. LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH APPLICATIONS
  • 7.3. CLINICAL & DIAGNOSTIC APPLICATIONS
  • 7.4. OTHER APPLICATIONS

8. LIFE SCIENCE INSTRUMENTATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. CELL COUNTING
    • 8.2.1. RESEARCH INSTITUTIONS
    • 8.2.2. HOSPITALS AND DIAGNOSTIC LABORATORIES
    • 8.2.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.2.4. OTHER END USERS
  • 8.3. CENTRIFUGES
    • 8.3.1. HOSPITALS
    • 8.3.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • 8.3.3. ACADEMIC AND RESEARCH INSTITUTES
  • 8.4. CHROMATOGRAPHY
    • 8.4.1. PHARMACEUTICAL COMPANIES AND CROS
    • 8.4.2. BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES
    • 8.4.3. ACADEMIC RESEARCH LABORATORIES
    • 8.4.4. AGRICULTURE & FOOD INDUSTRY
    • 8.4.5. ENVIRONMENTAL TESTING
    • 8.4.6. OTHER END USERS
  • 8.5. CLINICAL CHEMISTRY ANALYZERS
    • 8.5.1. HOSPITALS-BASED LABORATORIES
    • 8.5.2. DIAGNOSTIC LABORATORIES
    • 8.5.3. ACADEMIC RESEARCH CENTERS
    • 8.5.4. OTHER END USERS
  • 8.6. ELECTROPHORESIS
    • 8.6.1. ACADEMIC AND RESEARCH INSTITUTIONS
    • 8.6.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.6.3. HOSPITALS AND DIAGNOSTIC CENTERS
    • 8.6.4. OTHER END USERS
  • 8.7. FLOW CYTOMETRY
    • 8.7.1. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.7.2. MEDICAL SCHOOLS AND ACADEMIC INSTITUTIONS
    • 8.7.3. HOSPITALS
    • 8.7.4. RESEARCH INSTITUTES
    • 8.7.5. CLINICAL TESTING LABORATORIES
  • 8.8. IMMUNOASSAY
    • 8.8.1. HOSPITALS
    • 8.8.2. CLINICAL LABORATORIES
    • 8.8.3. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
    • 8.8.4. BLOOD BANKS
    • 8.8.5. RESEARCH AND ACADEMIC LABORATORIES
    • 8.8.6. OTHER END USERS
  • 8.9. LIQUID HANDLING
    • 8.9.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
    • 8.9.2. RESEARCH INSTITUTES
    • 8.9.3. HOSPITALS AND DIAGNOSTIC LABORATORIES
    • 8.9.4. ACADEMIC INSTITUTES
    • 8.9.5. OTHER END USERS
  • 8.10. LYOPHILIZATION
    • 8.10.1. FOOD PROCESSING AND PACKAGING COMPANIES
    • 8.10.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.10.3. HOSPITALS, BIOBANKS, AND LABS
    • 8.10.4. OTHER END USERS
  • 8.11. MICROSCOPY
    • 8.11.1. ACADEMIC INSTITUTES
    • 8.11.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.11.3. OTHER END USERS
  • 8.12. NEXT-GENERATION SEQUENCING
    • 8.12.1. ACADEMIC AND RESEARCH INSTITUTES
    • 8.12.2. HOSPITALS AND CLINICS
    • 8.12.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.12.4. OTHER END USERS
  • 8.13. PCR
    • 8.13.1. HOSPITALS AND DIAGNOSTIC CENTERS
    • 8.13.2. RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
    • 8.13.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 8.13.4. CLINICAL RESEARCH ORGANIZATIONS
    • 8.13.5. FORENSIC LABORATORIES
  • 8.14. SPECTROSCOPY
    • 8.14.1. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
    • 8.14.2. FOOD AND BEVERAGE INDUSTRY
    • 8.14.3. ENVIRONMENTAL TESTING
    • 8.14.4. INDUSTRIAL CHEMISTRY
    • 8.14.5. ACADEMIC INSTITUTIONS
    • 8.14.6. OTHER END USERS
  • 8.15. OTHER TECHNOLOGIES
    • 8.15.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS
    • 8.15.2. RESEARCH LABORATORIES
    • 8.15.3. ACADEMIC INSTITUTIONS
    • 8.15.4. OTHERS END USERS

9. LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES
    • 9.2.2. STRINGENT REGULATIONS DRIVING THE USE OF ANALYTICAL INSTRUMENTS IN DRUG DEVELOPMENT
    • 9.2.3. GROWING METABOLOMICS RESEARCH IN THE US
    • 9.2.4. CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS
  • 9.3. EUROPE
    • 9.3.1. PUBLIC-PRIVATE INVESTMENTS IN R&D ACTIVITIES
    • 9.3.2. RISING AWARENESS ON ADVANCED ANALYTICAL INSTRUMENTS
    • 9.3.3. DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA
  • 9.4. ASIA PACIFIC
    • 9.4.1. STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES
    • 9.4.2. RISING CROP RESEARCH STUDIES IN ASIA
    • 9.4.3. GOVERNMENT INVESTMENTS IN THE CHINESE BIOMEDICAL INDUSTRY
    • 9.4.4. SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE INSTRUMENTATION
    • 9.4.5. CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS
  • 9.5. REST OF THE WORLD
    • 9.5.1. GROWTH OF THE BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO
    • 9.5.2. INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION
    • 9.5.3. HIGH PREVALENCE OF HIV IN AFRICAN REGION

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS

11. COMPANY PROFILES (OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 11.1. AGILENT TECHNOLOGIES, INC.
  • 11.2. DANAHER CORPORATION
  • 11.3. PERKINELMER, INC.
  • 11.4. SHIMADZU CORPORATION
  • 11.5. THERMO FISHER SCIENTIFIC, INC.
  • 11.6. BECTON, DICKINSON AND COMPANY
  • 11.7. BIO-RAD LABORATORIES, INC.
  • 11.8. BRUKER CORPORATION
  • 11.9. WATERS CORPORATION
  • 11.10. GE HEALTHCARE
  • 11.11. HITACHI HIGH-TECHNOLOGIES CORPORATION
  • 11.12. MERCK KGAA
  • 11.13. QIAGEN N.V.
  • 11.14. HORIBA LTD.
  • 11.15. EPPENDORF AG

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: RECENT ACQUISITIONS, 2015-2017
  • TABLE 2: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 3: LIFE SCIENCE INSTRUMENTATION MARKET FOR SPECTROSCOPY, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 4: LIFE SCIENCE INSTRUMENTATION MARKET FOR SPECTROSCOPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: LIFE SCIENCE INSTRUMENTATION MARKET FOR MASS SPECTROMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: LIFE SCIENCE INSTRUMENTATION MARKET FOR MOLECULAR SPECTROMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: LIFE SCIENCE INSTRUMENTATION MARKET FOR ATOMIC SPECTROMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: LIFE SCIENCE INSTRUMENTATION MARKET FOR CHROMATOGRAPHY, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 9: LIFE SCIENCE INSTRUMENTATION MARKET FOR CHROMATOGRAPHY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: DIFFERENTIATION OF LIQUID CHROMATOGRAPHY SYSTEMS
  • TABLE 11: LIFE SCIENCE INSTRUMENTATION MARKET FOR LIQUID CHROMATOGRAPHY SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: LIFE SCIENCE INSTRUMENTATION MARKET FOR GAS CHROMATOGRAPHY SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: LIFE SCIENCE INSTRUMENTATION MARKET FOR SUPERCRITICAL FLUID CHROMATOGRAPHY SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: LIFE SCIENCE INSTRUMENTATION MARKET FOR THIN-LAYER CHROMATOGRAPHY SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: LIFE SCIENCE INSTRUMENTATION MARKET FOR PCR, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: LIFE SCIENCE INSTRUMENTATION MARKET FOR PCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: LIFE SCIENCE INSTRUMENTATION MARKET FOR QPCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: LIFE SCIENCE INSTRUMENTATION MARKET FOR DPCR, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: LIFE SCIENCE INSTRUMENTATION MARKET FOR IMMUNOASSAYS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: GLOBAL INCIDENCE OF INFECTIOUS DISEASES, 2015
  • TABLE 21: LIFE SCIENCE INSTRUMENTATION MARKET FOR LYOPHILIZATION, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 22: LIFE SCIENCE INSTRUMENTATION MARKET FOR LYOPHILIZATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: LIFE SCIENCE INSTRUMENTATION MARKET FOR TRAY-STYLE FREEZE DRYERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: LIFE SCIENCE INSTRUMENTATION MARKET FOR MANIFOLD FREEZE DRYERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: LIFE SCIENCE INSTRUMENTATION MARKET FOR SHELL FREEZE DRYERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: GLOBAL LYOPHILIZATION MARKET RANKING, TOP 5 PLAYERS, 2016
  • TABLE 27: GLOBAL LIQUID HANDLING MARKET, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: LIFE SCIENCE INSTRUMENTATION MARKET FOR LIQUID HANDLING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: LIFE SCIENCE INSTRUMENTATION MARKET FOR ELECTRONIC LIQUID HANDLING SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: LIFE SCIENCE INSTRUMENTATION MARKET FOR AUTOMATED LIQUID HANDLING SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: LIFE SCIENCE INSTRUMENTATION MARKET FOR MANUAL LIQUID HANDLING SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: LIFE SCIENCE INSTRUMENTATION MARKET FOR CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET RANKING, TOP 6 PLAYERS, 2016
  • TABLE 34: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROSCOPY, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 35: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROSCOPY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: LIFE SCIENCE INSTRUMENTATION MARKET FOR OPTICAL MICROSCOPES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: LIFE SCIENCE INSTRUMENTATION MARKET FOR ELECTRON MICROSCOPES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: LIFE SCIENCE INSTRUMENTATION MARKET FOR SCANNING PROBE MICROSCOPES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: LIFE SCIENCE INSTRUMENTATION MARKET FOR OTHER MICROSCOPES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: LIFE SCIENCE INSTRUMENTATION MARKET FOR FLOW CYTOMETRY, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 41: LIFE SCIENCE INSTRUMENTATION MARKET FOR FLOW CYTOMETRY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: LIFE SCIENCE INSTRUMENTATION MARKET FOR CELL ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: LIFE SCIENCE INSTRUMENTATION MARKET FOR CELL SORTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: LIFE SCIENCE INSTRUMENTATION MARKET FOR NGS PLATFORMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 45: LIST OF SEQUENCING PLATFORMS LAUNCHED BETWEEN 2015 AND 2017
  • TABLE 46: LIFE SCIENCE INSTRUMENTATION MARKET FOR CENTRIFUGES, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: LIFE SCIENCE INSTRUMENTATION MARKET FOR CENTRIFUGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 48: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROCENTRIFUGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 49: LIFE SCIENCE INSTRUMENTATION MARKET FOR MULTIPURPOSE CENTRIFUGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 50: LIFE SCIENCE INSTRUMENTATION MARKET FOR FLOOR-STANDING CENTRIFUGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 51: LIFE SCIENCE INSTRUMENTATION MARKET FOR ULTRACENTRIFUGES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 52: GLOBAL CENTRIFUGES MARKET RANKING, TOP 5 PLAYERS, 2016
  • TABLE 53: LIFE SCIENCE INSTRUMENTATION MARKET FOR ELECTROPHORESIS, BY PRODUCT TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: LIFE SCIENCE INSTRUMENTATION MARKET FOR ELECTROPHORESIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 55: GEL ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 56: CAPILLARY ELECTROPHORESIS SYSTEMS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 57: LIFE SCIENCE INSTRUMENTATION MARKET FOR CELL COUNTING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: LIFE SCIENCE INSTRUMENTATION MARKET FOR CELL COUNTING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 59: LIFE SCIENCE INSTRUMENTATION MARKET FOR AUTOMATED CELL COUNTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 60: LIFE SCIENCE INSTRUMENTATION MARKET FOR HEMOCYTOMETERS AND MANUAL CELL COUNTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 61: GLOBAL CELL COUNTING MARKET RANKING, TOP 5 PLAYERS, 2016
  • TABLE 62: OTHER LIFE SCIENCE INSTRUMENTATION TECHNOLOGIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: OTHER LIFE SCIENCE INSTRUMENTATION TECHNOLOGIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 64: LIFE SCIENCE INSTRUMENTATION MARKET FOR LABORATORY FREEZERS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: LIFE SCIENCE INSTRUMENTATION MARKET FOR LABORATORY FREEZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 66: LIFE SCIENCE INSTRUMENTATION MARKET FOR HEAT STERILIZATION, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: LIFE SCIENCE INSTRUMENTATION MARKET FOR HEAT STERILIZATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 68: STERILIZATION TEMPERATURE BANDS, HOLDING TIMES, AND PRESSURES FOR STEAM STERILIZATION
  • TABLE 69: DRYING CYCLES RECOMMENDED AS PER BP (BRITISH PHARMACOPEIA), 1988
  • TABLE 70: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROPLATE SYSTEMS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 71: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROPLATE SYSTEMS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 72: LIFE SCIENCE INSTRUMENTATION MARKET FOR LABORATORY BALANCES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 73: LIFE SCIENCE INSTRUMENTATION MARKET FOR COLORIMETERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 74: LIFE SCIENCE INSTRUMENTATION MARKET FOR INCUBATORS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 75: LIFE SCIENCE INSTRUMENTATION MARKET FOR FUME HOODS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 76: LIFE SCIENCE INSTRUMENTATION MARKET FOR MICROPLATE SYSTEMS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: LIFE SCIENCE INSTRUMENTATION MARKET FOR STANDALONE ROBOTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 78: LIFE SCIENCE INSTRUMENTATION MARKET FOR PH METERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 79: LIFE SCIENCE INSTRUMENTATION MARKET FOR CONDUCTIVITY AND RESISTIVITY METERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 80: LIFE SCIENCE INSTRUMENTATION MARKET FOR DISSOLVED CO2 AND O2 METERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 81: LIFE SCIENCE INSTRUMENTATION MARKET FOR TITRATORS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 82: LIFE SCIENCE INSTRUMENTATION MARKET FOR GAS ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 83: LIFE SCIENCE INSTRUMENTATION MARKET FOR TOC ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 84: LIFE SCIENCE INSTRUMENTATION MARKET FOR THERMAL ANALYZERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 85: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION, 2015-2022 (USD BILLION)
  • TABLE 86: GLOBAL CELL COUNTING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 87: GLOBAL CENTRIFUGES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 88: FUNDING FOR RESEARCH
  • TABLE 89: GLOBAL CHROMATOGRAPHY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 90: GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 91: GLOBAL ELECTROPHORESIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 92: GLOBAL FLOW CYTOMETRY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 93: GLOBAL IMMUNOASSAY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 94: GLOBAL LIQUID HANDLING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 95: GLOBAL LYOPHILIZATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 96: GLOBAL MICROSCOPY MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 97: GLOBAL NGS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 98: GLOBAL PCR MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 99: GLOBAL SPECTROSCOPY MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 100: GLOBAL OTHER TECHNOLOGIES MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 101: LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION, 2015-2022 (USD BILLION)
  • TABLE 102: NORTH AMERICA: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 103: EUROPE: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 104: ASIA PACIFIC: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 105: HIV INFECTIONS AND AIDS-RELATED DEATHS IN THE MIDDLE EAST AND AFRICA, 2016
  • TABLE 106: ROW: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: DATA TRIANGULATION
  • FIGURE 5: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 6: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET IN 2017
  • FIGURE 8: LEADING PLAYERS IN THE GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET
  • FIGURE 9: INCREASING PHARMACEUTICAL R&D EXPENDITURE AND TECHNOLOGICAL ADVANCEMENTS DRIVING MARKET GROWTH
  • FIGURE 10: SPECTROSCOPY AND NORTH AMERICA TO DOMINATE THE LIFE SCIENCE INSTRUMENTATION MARKET IN 2017
  • FIGURE 11: NGS TO GROW AT THE FASTEST RATE IN THE MARKET, BY TECHNOLOGY, DURING 2017-2022
  • FIGURE 12: RESEARCH APPLICATIONS SEGMENT TO CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: LIFE SCIENCE INSTRUMENTATION MARKET, BY TECHNOLOGY, 2017 (USD BILLION)
  • FIGURE 16: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE SPECTROSCOPY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 17: GLOBAL SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 18: NORTH AMERICA TO WITNESS HIGHEST GROWTH IN CHROMATOGRAPHY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 19: GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 20: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN PCR SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 21: QPCR MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 22: DPCR MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 23: ASIA PACIFIC TO GROW AT THE HIGHEST CAGR IN IMMUNOASSAYS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 24: GLOBAL IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 25: ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN LYOPHILIZATION SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 26: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN LIQUID HANDLING SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 27: GLOBAL LIQUID HANDLING MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 28: ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN CLINICAL CHEMISTRY ANALYZERS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 29: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MICROSCOPY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 30: GLOBAL MICROSCOPES MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 31: ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN FLOW CYTOMETRY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 32: GLOBAL FLOW CYTOMETRY MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 33: ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN NGS PLATFORMS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 34: GLOBAL NGS PLATFORMS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 35: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN CENTRIFUGES SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 36: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN ELECTROPHORESIS SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 37: GEL ELECTROPHORESIS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 38: CAPILLARY ELECTROPHORESIS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 39: NORTH AMERICA TO REGISTER HIGHEST GROWTH IN CELL COUNTING SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 40: ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN OTHER TECHNOLOGIES SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 41: RESEARCH APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE LIFE SCIENCE INSTRUMENTATION MARKET IN 2017
  • FIGURE 42: RESEARCH INSTITUTIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL COUNTING MARKET IN 2017
  • FIGURE 43: HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CENTRIFUGES MARKET IN 2017
  • FIGURE 44: PHARMACEUTICAL COMPANIES AND CROS TO DOMINATE THE GLOBAL CHROMATOGRAPHY MARKET IN 2017
  • FIGURE 45: HOSPITALS SEGMENT HOLD THE LARGEST SHARE OF THE GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET
  • FIGURE 46: ACADEMIC INSTITUTIONS TO HOLD THE LARGEST SHARE OF THE GLOBAL ELECTROPHORESIS MARKET IN 2017
  • FIGURE 47: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL FLOW CYTOMETRY MARKET IN 2017
  • FIGURE 48: HOSPITALS TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IMMUNOASSAY MARKET
  • FIGURE 49: BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES HOLD THE LARGEST SHARE OF THE GLOBAL LIQUID HANDLING MARKET
  • FIGURE 50: FOOD PROCESSING AND PACKAGING COMPANIES HOLD THE LARGEST SHARE OF THE GLOBAL LYOPHILIZATION MARKET
  • FIGURE 51: ACADEMIC INSTITUTES HOLD THE LARGEST SHARE OF THE GLOBAL MICROSCOPY MARKET
  • FIGURE 52: ACADEMIC AND RESEARCH INSTITUTES HOLD THE LARGEST SHARE OF GLOBAL NGS MARKET
  • FIGURE 53: HOSPITALS AND DIAGNOSTIC CENTERS HOLD THE LARGEST SHARE OF THE GLOBAL PCR MARKET
  • FIGURE 54: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS HOLD THE LARGEST SHARE OF THE GLOBAL SPECTROSCOPY MARKET
  • FIGURE 55: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS HOLD THE LARGEST SHARE OF OTHER TECHNOLOGIES MARKET
  • FIGURE 56: ASIA PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 57: NORTH AMERICA: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT
  • FIGURE 58: EUROPE: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT
  • FIGURE 59: ASIA PACIFIC: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT
  • FIGURE 60: ROW: LIFE SCIENCE INSTRUMENTATION MARKET SNAPSHOT
  • FIGURE 61: GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
  • FIGURE 62: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 63: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 64: PERKINELMER, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 65: SHIMADZU CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 66: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 67: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
  • FIGURE 68: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 69: BRUKER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 70: WATERS CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 71: GE HEALTHCARE: COMPANY SNAPSHOT (2016)
  • FIGURE 72: HITACHI HIGH-TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 73: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 74: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 75: HORIBA LTD.: COMPANY SNAPSHOT (2016)
  • FIGURE 76: EPPENDORF AG: COMPANY SNAPSHOT (2016)
Back to Top